DoD FY15 Spinal Cord Injury Translational Research Award

The summary for the DoD FY15 Spinal Cord Injury Translational Research Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DoD FY15 Spinal Cord Injury Translational Research Award: The SCIRP Translational Research Award is intended to support translational research that will accelerate the movement of promising ideas in spinal cord injury research into clinical applications. Although not all inclusive, some examples include demonstration studies of pharmaceuticals and medical devices in preclinical systems, and/or clinical research on therapeutics, devices, or practice using human tissues or resources. Observations that drive a research idea may be derived from a laboratory discovery, population-based studies, or a clinician’s first-hand knowledge of patients and anecdotal data.

Optional Qualified Collaborator: The FY15 SCIRP strongly encourages multidisciplinary collaborations among academic scientists and clinicians, industry scientists, the military Services, the VA, and other Federal Government agencies. Collaborations with early-career investigators in the SCI field are encouraged. Although more than one collaborator may participate in the application, only one may be named for this option.

The FY15 SCIRP encourages applications that specifically address one or more of the following areas:
1. Pre-hospital, en route care, and early hospital management of SCI
2. Development, validation, and timing of promising interventions to address consequences of SCI and to improve recovery, including, but not limited to:
• Bladder, bowel, and autonomic dysfunction
• Cardiometabolic dysfunction
• Neuropathic pain and sensory dysfunction
• Pressure ulcers
• Respiratory dysfunction
• Sexual dysfunction
3. Identification and validation of best practices in SCI care including but not limited to:
• Critical care interventions
• Interventions for musculoskeletal health
• Rehabilitation interventions
• Surgical interventions
• Psychosocial and behavioral interventions in military/Veteran populations